Technical Analysis for IXI - Ixico Plc

Grade Last Price % Change Price Change
C 8.64 -1.26% -0.11
IXI closed unchanged on Tuesday, April 23, 2024, on 5 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
20 DMA Support Bullish -1.26%
Crossed Above 50 DMA Bullish -1.26%
Bollinger Band Squeeze Range Contraction -1.26%
50 DMA Resistance Bearish -1.26%
20 DMA Support Bullish -1.26%
Bollinger Band Squeeze Range Contraction -1.26%
Doji - Bearish? Reversal -1.26%
20 DMA Support Bullish -1.26%
Hammer Candlestick Bullish -1.26%
Lizard Bullish Bullish Day Trade Setup -1.26%

   Recent Intraday Alerts

Alert Time
Down 1% about 3 hours ago
Possible Inside Day about 3 hours ago
Possible NR7 about 3 hours ago
Fell Below 50 DMA about 3 hours ago
Fell Below 20 DMA about 3 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Ixico Plc Description

IXICO plc is a brain health company. The Company's brain health focus includes Alzheimer's disease, Huntington's disease, Parkinson's disease, behavioral health and adolescent mental health. It is a provider of clinical trials services to pharmaceutical companies. Its products include Assessa, mehealth, MyBrainBook and TrialTracker. Assessa is a decision-support tool for healthcare professionals looking to diagnose dementia and detect the underlying causes. mehealth is an online software for clinicians at the point-of-care to support decision making and improve the monitoring and treatment of patients. MyBrainBook is a digital platform to improve the quality of life and service delivery for people living with dementia and their supporters. TrialTracker is a Web-based system that allows users to track their imaging-based research study or clinical trial in real time. It is also collaborating with partners to develop companion digital health products.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Healthcare Software Pharmaceutical Quality Medicine Disease Clinic Monitoring Imaging Clinical Trial Healthcare Professionals Alzheimer's Disease Eim Health Products Parkinson's Disease Mental Health Dementia Pharmaceutical Companies Aging Associated Diseases Huntington's Disease Medical Diagnosis Psychiatric Diagnosis Psychiatry

Is IXI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 21.0
52 Week Low 6.35
Average Volume 100,572
200-Day Moving Average 14.34
50-Day Moving Average 8.73
20-Day Moving Average 8.63
10-Day Moving Average 8.75
Average True Range 0.39
RSI (14) 52.15
ADX 20.26
+DI 17.41
-DI 12.05
Chandelier Exit (Long, 3 ATRs) 7.84
Chandelier Exit (Short, 3 ATRs) 9.17
Upper Bollinger Bands 9.06
Lower Bollinger Band 8.19
Percent B (%b) 0.64
BandWidth 10.02
MACD Line 0.02
MACD Signal Line -0.03
MACD Histogram 0.0452
Fundamentals Value
Market Cap 4.23 Million
Num Shares 48.4 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -437.50
Price-to-Sales 0.74
Price-to-Book 0.43
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.43
Resistance 3 (R3) 9.42 9.18 9.31
Resistance 2 (R2) 9.18 9.01 9.19 9.27
Resistance 1 (R1) 8.97 8.91 8.98 8.98 9.24
Pivot Point 8.73 8.73 8.74 8.74 8.73
Support 1 (S1) 8.52 8.56 8.53 8.53 8.26
Support 2 (S2) 8.28 8.46 8.29 8.23
Support 3 (S3) 8.07 8.28 8.19
Support 4 (S4) 8.08